featured
Efficacy of Semaglutide in Patients With Heart Failure and Mildly Reduced or Preserved Ejection Fraction
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
Lancet 2024 Sep 07;404(10456)949-961, MN Kosiborod, J Deanfield, R Pratley, BA Borlaug, J Butler, MJ Davies, SS Emerson, SE Kahn, DW Kitzman, I Lingvay, KW Mahaffey, MC Petrie, J Plutzky, S Rasmussen, C Rönnbäck, SJ Shah, S Verma, PE Weeke, AM LincoffFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.